GSK plc
corporate_fare Company Profile
GSK plc (NYSE:GSK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 65 items for GSK at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- GSK to acquire RAPT Therapeutics for $2.2 billion, boosting immunology pipeline
- GSK Simplifies ViiV Healthcare Ownership, Receives $250M Dividend as Shionogi Increases Stake
- GSK Announces Positive Phase 3 Results for Bepirovirsen in Chronic Hepatitis B, Meeting Primary Endpoints
- GSK's Exdensur Approved in Japan for Severe Asthma and CRSwNP, Expanding Global Reach
- GSK's Nucala Approved in China for COPD, Targeting Large Patient Population
Financial Snapshot
Insider Transactions
GSK files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.